期刊
CELL METABOLISM
卷 32, 期 3, 页码 341-352出版社
CELL PRESS
DOI: 10.1016/j.cmet.2020.06.019
关键词
-
资金
- NIH [5T32CA9560-33, 5R35CA197532]
- Northwestern University Pulmonary and Critical Care Department's Cugell Fellowship
Recent evidence in humans and mice supports the notion that mitochondrial metabolism is active and necessary for tumor growth. Mitochondrial metabolism supports tumor anabolism by providing key metabolites for macromolecule synthesis and generating oncometabolites to maintain the cancer phenotype. Moreover, there are multiple clinical trials testing the efficacy of inhibiting mitochondrial metabolism as a new cancer therapeutic treatment. In this review, we discuss the rationale of using these anti-cancer agents in clinical trials and highlight how to effectively utilize them in different tumor contexts.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据